Clinical trials
Renal Insufficiency, Chronic trials in China with unknown status
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
64 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 1 |
| 2004 | 1 |
| 2006 | 1 |
| 2009 | 2 |
| 2011 | 1 |
| 2012 | 5 |
| 2013 | 4 |
| 2014 | 4 |
| 2015 | 6 |
| 2016 | 4 |
| 2017 | 2 |
| 2018 | 4 |
| 2019 | 3 |
| 2020 | 3 |
| 2021 | 3 |
| 2022 | 6 |
| 2023 | 12 |
| 2024 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Unknown status | 64 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Chinese PLA General Hospital | 3 |
| Guangdong Provincial People's Hospital | 3 |
| The Affiliated Hospital of Xuzhou Medical University | 3 |
| Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | 2 |
| Fifth Affiliated Hospital, Sun Yat-Sen University | 2 |
| Limeng Chen | 2 |
| Peking Union Medical College Hospital | 2 |
| Peking University First Hospital | 2 |
| Peking University People's Hospital | 2 |
| Shandong Suncadia Medicine Co., Ltd. | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Renal Insufficiency, Chronic | 64 |
| Cardiovascular Diseases | 4 |
| Kidney Failure, Chronic | 4 |
| Diabetes Mellitus | 3 |
| Proteinuria | 3 |
| COVID-19 | 2 |
| Chronic Kidney Disease-Mineral and Bone Disorder | 2 |
| Disease | 2 |
| Hypertension | 2 |
| Hyperuricemia | 2 |
Trials
Showing 1 to 25 of 64. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.